S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
NYSE:NNVC

NanoViricides (NNVC) Stock Forecast, Price & News

$1.10
-0.03 (-2.65%)
(As of 06/7/2023 ET)
Compare
Today's Range
$1.10
$1.19
50-Day Range
$1.05
$1.63
52-Week Range
$1.04
$3.88
Volume
19,129 shs
Average Volume
37,383 shs
Market Capitalization
$12.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25

NanoViricides MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
377.3% Upside
$5.25 Price Target
Short Interest
Healthy
2.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

Medical Sector

760th out of 981 stocks

Pharmaceutical Preparations Industry

362nd out of 463 stocks


NNVC stock logo

About NanoViricides (NYSE:NNVC) Stock

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

NNVC Stock News Headlines

[Strong Buy Alert] Is this laser stock in your portfolio?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? There are very few opportunities like this in today's bear market... But our analysts identified a tiny defense company landing billions of dollars in contracts every year.
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
NanoViricides (NYSE:NNVC) Now Covered by StockNews.com
StockNews.com Begins Coverage on NanoViricides (NYSE:NNVC)
NanoViricides (NYSE:NNVC) Coverage Initiated at StockNews.com
See More Headlines

NNVC Price History

NNVC Company Calendar

Last Earnings
11/15/2021
Today
6/07/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.25
High Stock Price Forecast
$5.25
Low Stock Price Forecast
$5.25
Forecasted Upside/Downside
+377.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-8,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.00 per share

Miscellaneous

Free Float
11,123,000
Market Cap
$12.80 million
Optionable
Optionable
Beta
1.10

Key Executives

  • Anil R. Diwan
    Executive Chairman, President & CEO
  • Meeta R. Vyas
    Chief Financial & Accounting Officer
  • Randall W. Barton
    Chief Scientific Officer
  • Jayant Tatake
    Vice President-Research & Development













NNVC Stock - Frequently Asked Questions

Should I buy or sell NanoViricides stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoViricides in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NNVC shares.
View NNVC analyst ratings
or view top-rated stocks.

What is NanoViricides' stock price forecast for 2023?

1 Wall Street research analysts have issued 12 month price targets for NanoViricides' stock. Their NNVC share price forecasts range from $5.25 to $5.25. On average, they expect the company's stock price to reach $5.25 in the next twelve months. This suggests a possible upside of 377.3% from the stock's current price.
View analysts price targets for NNVC
or view top-rated stocks among Wall Street analysts.

How have NNVC shares performed in 2023?

NanoViricides' stock was trading at $1.11 at the beginning of the year. Since then, NNVC shares have decreased by 0.9% and is now trading at $1.10.
View the best growth stocks for 2023 here
.

Are investors shorting NanoViricides?

NanoViricides saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 323,800 shares, a decrease of 21.0% from the April 30th total of 410,100 shares. Based on an average daily volume of 42,400 shares, the short-interest ratio is currently 7.6 days. Currently, 2.9% of the company's stock are sold short.
View NanoViricides' Short Interest
.

How were NanoViricides' earnings last quarter?

NanoViricides, Inc. (NYSE:NNVC) announced its quarterly earnings data on Monday, November, 15th. The company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $0.03.

When did NanoViricides' stock split?

Shares of NanoViricides reverse split before market open on Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE) under the ticker symbol "NNVC."

How do I buy shares of NanoViricides?

Shares of NNVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $1.10.

How much money does NanoViricides make?

NanoViricides (NYSE:NNVC) has a market capitalization of $12.80 million. The company earns $-8,110,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Drive, Shelton CT, 06484. The official website for the company is www.nanoviricides.com. The company can be reached via phone at (203) 937-6137, via email at clyburn@tradigitalir.com, or via fax at 203-859-5095.

This page (NYSE:NNVC) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -